GR antagonists block stress-induced activation of the ventral hippocampus [24], prevent anxiety-like behavior [25], improve susceptibility to chronic stress [26], and eliminate anxiety-like behavior induced by traumatic brain injury [70]. Here, NR3C1 is linked to injury.